Cargando…
Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA)
PURPOSE: To assess the extended efficacy and safety of suprachoroidal triamcinolone acetonide injectable suspension (CLS-TA) among patients with macular oedema (ME) secondary to non-infectious uveitis (NIU). METHODS: Patients with uveitic ME were treated with suprachoroidal CLS-TA at baseline and we...
Autores principales: | Khurana, Rahul N, Merrill, Pauline, Yeh, Steven, Suhler, Eric, Barakat, Mark R, Uchiyama, Eduardo, Henry, Christopher Ryan, Shah, Milan, Wang, Robert C, Kapik, Barry, Ciulla, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340030/ https://www.ncbi.nlm.nih.gov/pubmed/33712478 http://dx.doi.org/10.1136/bjophthalmol-2020-317560 |
Ejemplares similares
-
Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA)
por: Henry, Christopher Ryan, et al.
Publicado: (2022) -
Suprachoroidal triamcinolone acetonide versus rescue therapies for the treatment of uveitic macular oedema: A post hoc analysis of PEACHTREE
por: Singer, Michael A., et al.
Publicado: (2021) -
CLs
Publicado: (1998) -
Triamcinolone Acetonide Suprachoroidal Injectable Suspension for Uveitic Macular Edema: Integrated Analysis of Two Phase 3 Studies
por: Yeh, Steven, et al.
Publicado: (2022) -
Intravitreal aflibercept for treatment of macular oedema associated with immune recovery uveitis
por: Rothova, Aniki, et al.
Publicado: (2020)